GenMont Biotech Incorporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 78.454 million compared to TWD 86.240 million a year ago. Net income was TWD 15.146 million compared to TWD 4.176 million a year ago. Basic earnings per share was TWD 0.17 compared to TWD 0.05 a year ago. For the half year, sales was TWD 158.974 million compared to TWD 177.328 million a year ago. Net income was TWD 24.063 million compared to TWD 45.337 million a year ago. Basic earnings per share was TWD 0.27 compared to TWD 0.51 a year ago.